Flerie AB
1NP1
Company Profile
Business description
Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations.
Contact
Skeppsbron 16
Stockholm111 30
SWET: +46 761310127
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
9
Stocks News & Analysis
stocks
2 ASX shares that benefit from sticky inflation
Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks
Undervalued ASX retailer benefiting from rebound in spending
Uplift in sales momentum continues.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,917.50 | 13.80 | -0.15% |
| CAC 40 | 8,068.62 | 17.14 | -0.21% |
| DAX 40 | 24,186.49 | 108.12 | -0.45% |
| Dow JONES (US) | 48,458.05 | 245.96 | -0.51% |
| FTSE 100 | 9,649.03 | 54.13 | -0.56% |
| HKSE | 25,763.85 | 212.94 | -0.82% |
| NASDAQ | 23,195.17 | 398.69 | -1.69% |
| Nikkei 225 | 49,994.30 | 842.25 | -1.66% |
| NZX 50 Index | 13,399.20 | 7.71 | -0.06% |
| S&P 500 | 6,827.41 | 73.59 | -1.07% |
| S&P/ASX 200 | 8,628.60 | 15.30 | -0.18% |
| SSE Composite Index | 3,884.93 | 4.41 | -0.11% |